Ionian Technologies, Inc. is a privately held biotechnology company that is developing isothermal nucleic acid amplification technology. This technology has many attributes that make it an ideal choice for clinical and point-of-care diagnostics. It has also been used as a core component for pathogen detection systems. Ionian's isothermal amplification approach is based upon the NEAR Assay, which provides exquisite sensitivity coupled with rapid amplification speed. The NEAR Assay permits the amplification of DNA and RNA in approximately 5 minutes, with sensitivity and specificity equal to or better than PCR. The amplification products can be easily detected using a variety of methods that are compatible with point-of-care devices. Ionian's assay technology is therefore ideally suited for portable and handheld detectors and sensors, where very rapid identification is required. Ionian is currently focused on the development of products for the medical diagnostics, agricultural (GMO), veterinary, food hygiene and biodefense markets. Ionian has worked closely with a number of companies and Government organizations to develop rapid detection systems for biothreat agents. Please see our list of collaborators for more information. Founded in 2000, Ionian is headquartered in San Diego, CA.